Abstract: The year 2018 witnessed the introduction of  multiple management guidelines for systemic lupus erythematosus,  rheumatoid arthritis and psoriatic arthritis.  The treatment of rheumatic disease also went into more details which not only focused on systemic diseases,  but also on single organ and symptom. And the related guidelines are also coming. Drug treatment is more cautious and extends to the screening of infection,  cancer and comorbidity  management.   Multidisciplinary cooperation has become a trend. And imaging examinations in diagnosis,  nondrug therapies  and psychological needs of patients in treatment have all received attention.  The classification of diseases also has been placed on the agenda.  The clinical researches is attracting more and more public attention,  especially in terms of the study of biological agents.

Key words: erythematosus lupus, systemic, arthritis；vasculitis, hyperuricemia, autoinflammatory diseases